SAVIMS

This site is still under construction - more information to follow

August 2024

Events

Next SAVIMS meeting

Date: 29 August 2024 Time: 18:30 Agenda Please try your best to attend. We need input and discussion on this important issue! Welcome: Dr Herman Edeling. SAVIMS mpox press release: Response, Effect, Outcomes. (General discussion introduced by Dr Herman Edeling) Website, Constitution etc. (General discussion introduced by Dr Herman Edeling) Zoom link will be posted […]

News, SAVIMS Documents, SAVIMS Publications, Vaccines

IMMEDIATE RELEASE: Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox.

Johannesburg, South Africa – 18 August 2024 Click here to download PDF of this press release We are deeply concerned about the recent announcements made by Africa CDC Director General Jean Kaseya on 13 August 2024 and WHO Director-General Tedros Adhanom Ghebreyesus on 14 August 2024. It is important to address these announcements openly to

COVID-19, Reference Library

Early Ambulatory Multidrug Therapy Procter McCullough

Summary This study examined early ambulatory multidrug therapy for high risk COVID 19 patients to reduce hospitalisation and death rates. The research included 869 cases, with 320 cases from April to September 2020 and 549 cases from September to December 2020. The treatment protocol involved antiviral agents, antibiotics, inhaled medications, and intravenous supplements. In the

COVID-19, Reference Library

UK Vaccine Report Week 42

Summary The latest UK COVID 19 vaccine surveillance report for week 42 shows various vaccines are effective against symptomatic disease, especially the Delta variant. Vaccination coverage is high in older age groups, with reduced transmission risk and lower rates of cases, hospitalisations, and deaths in vaccinated individuals. The report also includes data on emergency care

COVID-19, Reference Library

FLCCC I MASK Plus Protocol

Summary The document outlines the I MASK+ Protocol for COVID 19 prevention and early outpatient treatment, including the use of ivermectin and other medications, as well as general preventive measures like wearing masks and hand hygiene. It emphasises the importance of vaccines and early treatment in consultation with healthcare providers. The protocol includes dosing guidelines,

COVID-19, Reference Library

Comprehensive investigations revealed consistent pathophysiological alterations after vaccination

Summary The study examined immune responses following vaccination with inactivated SARS CoV 2, revealing alterations in gene expression in immune cell types. These changes included heightened NF κB signalling and reduced type I interferon responses, resembling patterns seen in COVID 19 patients. Clinical laboratory findings post vaccination showed electrolyte imbalances, coagulation profile shifts, and renal

COVID-19, Reference Library, SAVIMS Publications

SARS CoV 2 Natural Immunity vs Vaccine Immunity

This Israeli study compares natural immunity to vaccine induced immunity against the Delta variant of SARS CoV 2. Analysing data from Maccabi Healthcare Services, it found that previously infected individuals had significantly lower risks of reinfection and symptomatic COVID 19 than those who were only vaccinated. Vaccinated individuals were 13.06 times more likely to have

COVID-19, Reference Library, SAVIMS Publications

Pfizer vaccine Effects Herve Seligmann Evaluation

The document by Hervé Seligmann evaluates the effects of the Pfizer COVID 19 vaccine. It raises concerns about potential adverse effects and the adequacy of clinical trial data. The analysis suggests that there may be underreporting of negative outcomes and emphasises the importance of comprehensive post vaccination monitoring to ensure safety and efficacy. The report

Scroll to Top